SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-198973
Filing Date
2019-07-22
Accepted
2019-07-22 16:01:56
Documents
3
Period of Report
2019-07-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d744262d8k.htm 8-K 23158
2 EX-99.1 d744262dex991.htm EX-99.1 9771
3 GRAPHIC g744262g0722084227930.jpg GRAPHIC 2506
  Complete submission text file 0001193125-19-198973.txt   37819
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 19965671
SIC: 2834 Pharmaceutical Preparations